Tag: Cancer Research
-
First patient in Arizona treated with new immune-cell therapy at HonorHealth Research Institute
Patients with synovial sarcoma, a soft-tissue cancer that often affects joints in the arms and legs, usually have limited options and poor outcomes SCOTTSDALE, Ariz. — Dec. 11, 2025 — A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the first in Arizona treated…
-
HonorHealth Research Institute study proves safety of out-patient chemotherapy preparation for new melanoma cancer therapy
Nearly all patients successfully completed lymphodepletion at home, without the need for staying in a hospital overnight SCOTTSDALE, Ariz. — Nov. 18, 2025 — A leading-edge cellular therapy for treating melanoma cancer known as TIL (tumor infiltrating lymphocytes) requires removal of part of the tumor, isolating the tumor’s immune cells, multiplying them, and then infusing the…
-
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ — Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per…
-
Faknostics — Redefining Cancer Therapeutics Through FAK Targeting
Phoenix, AZ (October 30, 2025) – According to the American Cancer Society, 2024 marked the first time the United States reported more than 2 million new cancer cases in a single year, with an estimated 2,001,140 diagnoses. This is where FAKnostics plans to make a difference by targeting focal adhesion kinase (FAK), a protein found…
-
DeepSomatic method improves detection of cancer mutations
Study combines machine learning with expanded genetic training sets A new machine learning method called DeepSomatic can significantly improve the detection of genetic mutations potentially related to cancer, according to a study published in Nature Biotechnology. Genetic mutations that are acquired during a person’s life, called somatic variants, are often associated with tumors. Detecting these variants…
-
Calviri Taking the Next Steps to Help a Man’s Best Friend
Phoenix, AZ (October 15, 2025) – In the United States, an estimated six million dogs are diagnosed with cancer every year, making it the leading cause of death in adult dogs. This staggering reality is exactly where Calviri intends to step in—and change the story. Founded in 2017 by Stephen Albert Johnston and Kathryn Sykes,…
-
Binary Genomics Pioneers Universal Blood Test for Cancer Detection and Monitoring at Phoenix Bioscience Core
Phoenix, AZ (September 23, 2025) – In 2024, more than 600,000 people in the United States died from cancer. Yet, research shows that an estimated 30–50% of cancer deaths are preventable with proper screening and early detection. That is where Binary Genomics plans to make a difference. Founded by Michael T. Barrett, PhD, Abhijit A.…
-
New cancer test can warn patients up to 10 years before treatment is needed
Chronic lymphocytic leukemia is the most common adult leukemia, affecting the blood and bone marrow. A new method uses low-cost, widely available DNA methylation testing to track cancer progression and predict outcomes long before cancer treatment is required. Image by Shutterstock Scientists have developed a new test that can reveal when cancer began and how…
